Effects of nicotinic receptor agonists on beta-amyloid beta-sheet formation

Jpn J Pharmacol. 1999 Mar;79(3):393-6. doi: 10.1254/jjp.79.393.

Abstract

Previously we demonstrated that nicotinic acetylcholine receptor stimulation protects neurons against beta-amyloid (Abeta)-induced cytotoxicity. In the present study, the effects of nicotinic receptor agonists on the beta-sheet formation were investigated using a thioflavin T (ThT)-based fluorescence assay. Nicotine, cytisine (an alpha4beta2 agonist), and 3-(2,4)-dimethoxybenzylidene anabaseine (DMXB, an alpha7 agonist) did not reduce fluorescence intensity when these agents were added to the beta-sheet-formed Abeta. Simultaneous incubation of Abeta with nicotinic agonists also did not cause a reduction in fluorescence intensity. This data suggests that nicotinic receptor agonists do not influence the formation of the beta-sheet structure.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkaloids / pharmacology
  • Amyloid beta-Peptides / chemistry
  • Amyloid beta-Peptides / drug effects*
  • Azocines
  • Benzylidene Compounds / pharmacology
  • Hydrogen-Ion Concentration
  • Nicotine / pharmacology
  • Nicotinic Agonists / pharmacology*
  • Protein Structure, Secondary
  • Pyridines / pharmacology
  • Quinolizines

Substances

  • Alkaloids
  • Amyloid beta-Peptides
  • Azocines
  • Benzylidene Compounds
  • Nicotinic Agonists
  • Pyridines
  • Quinolizines
  • cytisine
  • Nicotine
  • 3-(2,4-dimethoxybenzylidene)anabaseine